Peter Welch actually said...

It is allowed to happen because there are no rules and there is no transparency either to the public to decide whether this is an appropriat...

Pharma is claiming that it spends all its money on R&D, but it won't show us the books.

I want transparency when there is a claim that it justifies the price increases.

I want four issues. One, R&D spending; 2, stock buybacks; 3, advertising; 4, executive compensation.